ONCC-BMTCN Dumps

ONCC-BMTCN Braindumps ONCC-BMTCN Real Questions ONCC-BMTCN Practice Test ONCC-BMTCN Actual Questions


killexams.com


Nursing


ONCC-BMTCN


ONCC Blood and Marrow Transplant Certified Nurse


https://killexams.com/pass4sure/exam-detail/ONCC-BMTCN

Question: 1


Which of the following is a common adverse effect of total body irradiation (TBI) as part of the preparative regimen for hematopoietic stem cell transplantation?


  1. Hypercalcemia


    hrombocytopenia ypoglycemia


    wer: B


    anation: Pulmonary fibrosis is a common adverse effect of total body iation (TBI) in the context of hematopoietic stem cell transplantation. ause damage to lung tissue, leading to the development of fibrosis an ired lung function. Regular monitoring and supportive care are import anage this complication.


    stion: 2


    ch of the following is an important aspect of late post-transplant agement and education?


    lood type compatibility testing enetic counseling

    Pulmonary fibrosis

  2. T

  3. H

Ans Expl

irrad TBI

can c d

impa ant

to m


Que


Whi man


  1. B

  2. G

  3. Fertility preservation options

  4. Allogeneic rescue transplant Answer: B

Explanation: Genetic counseling is an important aspect of late post-transplant management and education. Transplant recipients and their families may

benefit from genetic counseling to understand the genetic implications of the transplant, potential recurrence risks, and family planning options. This can help them make informed decisions regarding their future health and reproductive choices.


Question: 3


agement and education?


aintenance chemotherapy

fection prevention and management ong-term follow-up planning

onor lymphocyte infusion wer: B

anation: Infection prevention and management are key components of post-transplant management and education. Transplant recipients are ased risk of infections due to immunosuppression and the impact of t arative regimen. Proper infection prevention measures, early detection mpt treatment are vital to minimize infectious complications.


stion: 4


ch of the following is a commonly used mobilization agent for periphe

Which of the following is a key component of early post-transplant man


  1. M

  2. In

  3. L

  4. D

Ans Expl

early at

incre he

prep , and

pro


Que


Whi ral

blood stem cell collection?


  1. Filgrastim (G-CSF)

  2. Etoposide

  3. Cyclophosphamide

  4. Methotrexate

Answer: A


Explanation: Filgrastim (G-CSF) is a commonly used mobilization agent for peripheral blood stem cell collection. It stimulates the production and release of hematopoietic stem cells from the bone marrow into the peripheral blood. This allows for easier collection and subsequent infusion in the transplant recipient.



ch of the following is a long-term complication commonly associated nic graft-versus-host disease (GVHD)?


ypertension iabetes mellitus steoporosis yperthyroidism


wer: C


anation: Osteoporosis is a long-term complication commonly associat hronic graft-versus-host disease (GVHD). Chronic GVHD can affec health and lead to decreased bone density, increasing the risk of fract steoporosis. Regular monitoring, adequate calcium and vitamin D int ppropriate interventions are important in the management of this plication.

Question: 5


Whi with

chro


  1. H

  2. D

  3. O

  4. H


Ans


Expl ed

with c t

bone ures

and o ake,

and a com


Question: 6


Which of the following is the primary determinant of HLA compatibility between a donor and a recipient in hematopoietic stem cell transplantation?


  1. HLA-A antigens

  2. HLA-B antigens

  3. HLA-DR antigens

  4. HLA-DQ antigens Answer: C

plex. Matching HLA-DR antigens between a donor and a recipient is al for minimizing the risk of graft rejection and graft-versus-host dise HD).


stion: 7


ch of the following is a professional performance expectation for a TCN (ONCC Blood & Marrow Transplant Certified Nurse)?


erforming stem cell collection procedures rescribing immunosuppressive medications articipating in research studies dministering chemotherapy agents


wer: C


anation: Participating in research studies is a professional performanc ctation for a BMTCN (ONCC Blood & Marrow Transplant Certified

Explanation: HLA-DR antigens are the primary determinants of compatibility in hematopoietic stem cell transplantation. These antigens are cell surface proteins encoded by genes within the human leukocyte antigen (HLA)

com

cruci ase

(GV


Que


Whi BM


  1. P

  2. P

  3. P

  4. A


Ans


Expl e

expe

Nurse). BMTCNs are expected to actively engage in evidence-based practice and contribute to advancements in the field of blood and marrow transplantation. This includes participating in research studies, promoting best practices, and sharing knowledge with colleagues and the widerprofessional community.


Question: 8

Which of the following is a common quality-of-life concern for long-term survivors of hematopoietic stem cell transplantation?


  1. Hair loss

  2. Nausea and vomiting

  3. Neuropathy


    wer: D


    anation: Fatigue is a common quality-of-life concern for long-term vors of hematopoietic stem cell transplantation. Many survivors rience persistent fatigue even years after the transplant. This can have ficant impact on their overall well-being and daily functioning. Suppo

    easures and appropriate interventions are important in managing fat mproving quality of life.


    stion: 9


    ch of the following is an essential component of the informed consent ess for hematopoietic stem cell transplantation?


    escribing potential complications in detail uaranteeing a successful outcome

    ithholding information about alternative treatment options

    Fatigue Ans

Expl survi

expe a

signi rtive

care m igue

and i


Que


Whi proc


  1. D

  2. G

  3. W

  4. Obtaining consent from only the recipient Answer: A

Explanation: Describing potential complications in detail is an essential component of the informed consent process for hematopoietic stem cell transplantation. The informed consent process involves providing

comprehensive information about the procedure, potential risks and benefits, alternative treatment options, and the expected outcomes. It is important to ensure that patients and their families have a clear understanding of the potential complications involved before giving their consent.